Prepared by Dr. James Wilson, FRM, Head of Quantitative Research | Reviewed by Elena Voss, Lead Editor | Report ID: IGEMINI-4182DBA7-20260531 | Data as of 2026-05-31
Executive Summary: Our multi-factor model assigns cash flow positive properties a Bullish outlook for the next quarter. Key drivers include a P/E of 72.93x, -6.1% revenue expansion, and an RSI of 59 suggesting a neutral-bullish phase. We define critical support at $781.2 and resistance at $954.8.
Rating: Buy | Target Price: $1015.56 | Next Earnings: Jun 18
Download Full PDF Report
RSI at 59 indicates a neutral-bullish state. Historical backtests suggest a +10.5% move within 10 sessions.
Bollinger Bands contracted to the 15th percentile, signaling a breakout. A close above $998.2 would be bullish.
EPS of $11.9 reveals improving earnings quality. DuPont analysis highlights asset turnover as the key ROE driver.
With a market cap of $23.36B, cash flow positive properties operates in Healthcare. P/E of 72.93x is backed by -6.1% growth.
Options skew is toward call at the 833.28 strike, positioning for a directional move.
Beta of 1.79 suggests cash flow positive properties is {beta_desc} volatile than the market, influencing hedging strategies.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $868 | $824.6 |
| Market Cap | $23.36B | $25.7B |
| P/E Ratio | 72.93x | 62x |
| EPS (TTM) | $11.9 | $10.71 |
| Dividend Yield | 4.74% | 3.3% |
| Revenue Growth | -6.1% | -3.7% |
| Target Price | $1015.56 | - |
| Beta | 1.79 | 1.00 |